Chambers Global Practice Guide Life Sciences 2026

16 Apr 2026, estimated reading time 1 minute

We are excited to announce that our life sciences and healthcare law experts have made a contribution to the latest edition of the Chambers and Partners Global Practice Guide Life Sciences 2026 for the Netherlands.

The guide provides an overview of the relevant laws and regulations that govern the field of life sciences, as well as practical and valuable insights into a variety of trends and developments.

Our contribution to the guide covers topics such as:

• The regulatory framework governing medicinal products and medical devices
• Clinical trials
• Marketing authorisations
• Regulatory reliance and fast-track registration routes
• Manufacturing, distribution, import and export of medicinal products and medical devices
• Pricing and reimbursement of medicinal products and medical devices

Furthermore, the guide also explores some relevant trends and developments, such as the (upcoming revisions of key) EU laws governing the Dutch life sciences sector, the growing significance of artificial intelligence, the increased risk of class actions, accessibility and pricing of medicinal products, and increased litigation in the context of reimbursement.

Our contribution can be accessed here: https://practiceguides.chambers.com/practice-guides/life-sciences-2026/netherlands